What you'll learn
- *Evaluate molecularly targeted agents and immunotherapies approved or currently in clinical development for cancer treatment and incorporate into practice.
- *Assess relevant, state-of-the-art or translational pre-clinical models of anti-cancer therapies.
- Recognize the steps and determinants of the metastatic process of cancer.
- Identify the barrier for immunotherapy and potential approaches to address them.
- Compare correlative studies of biomarkers and their response and resistance to targeted therapies in cancer patients.
- Evaluate state-of-the-art genetic and imaging techniques and their applications in pre-clinical and clinical studies.
Course description
This is an accredited, livestreamed course offered by Massachusetts General Hospital and Edwin L. Steele Laboratories. This course is targeted to physicians and researchers.
Select the Take Course button to view additional information on the course registration page.
Contact ceprograms@hms.harvard.edu with questions.
*Register before September 15 to receive the discounted price.
Enroll now.
Learn MoreYou may also like
OnlineAn in-depth look at the 1854 London cholera epidemic in Soho and its importance for the field of epidemiology.Free*1 week longAvailable now- OnlineThis online course from Harvard Health Publishing helps demystify the way your brain works and gives you strategies to...$302 weeks longRegister byAug 9
- OnlineThis course offers proven strategies to counsel and motivate patients to improve their cooking habits for better health.$220Register byApr 11
